Study S000955

A Prospective Study of Patterns, Predictors, and Mechanisms of Weight Loss With Exenatide Treatment in Overweight and Obese Women Without Diabetes

Included trial: extracted data ClinicalTrials.gov record Study Protocol, Statistical Analysis Plan, and Informed Consent Form (PDF)

Registration

Registration: NCT01590433
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: COMPLETED
Enrollment: 249
Start: 2012-03
Primary completion: 2019-01
Lead sponsor: Jody Dushay
Conditions: Obesity
Interventions: DRUG:Exenatide; DRUG:Placebo; BEHAVIORAL:Dietary counseling
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Change in Body Weight [12 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0022102	Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women. Rodgers M, Frontiers in endocrinology	2021	Randomized trial	PMID 34867786 DOI	cites ClinicalTrials.gov:NCT01590433; registry reference DERIVED:34867786